top of page

Eyes on Pharma
Check-out What Intel Caught our Eye


EyesOn Clinical Updates
We've recently had EyesOn some of the Clinical data being released. Today we catch up with the details from Argenx, Zealand Pharma, and AbbVie data readouts.

Jana Chisholm
Nov 26 min read


Pharma Phriday (June 12, 2026)
Pharma Phriday (June 12, 2026). Oral drug delivery continued to reshape the obesity and HIV treatment landscapes. AI platform deals deepened beyond pilots into multi-year operational commitments. BD&L activity was substantial, spanning late-stage acquisitions, platform licensing, and preclinical bets. Regulatory milestones touched rare disease, oncology, and haematology. Several long-standing therapeutic hypotheses were either validated or refuted by Phase III data.
Duncan Emerton
Jun 1233 min read
bottom of page
.png)